hemotune raises CHF 5.1 million Series A funding
scroll south
OCCIDENT with participation of the Korean medical device company Green Cross Medical Science Corp. (GCMS), and Zürcher Kantonalbank led the investment in the ETH Zurich Spinoff.
hemotune AG, currently incubated at Wyss Zurich, today announced the closing of a CHF 5.1 million Series A to advance the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads. Despite the corona crisis, hemotune managed to build a very strong consortium led by OCCIDENT with participation of the Korean medical device company Green Cross Medical Science Corp. (GCMS), and Zürcher Kantonalbank.The Zurich-based startup received CHF 130.000 support from Venture Kick in 2017.
hemotune AG: Magnetic Blood Purification
hemotune AG is developping a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology. It allows specific and direct remova... Read more
